Home Cart 0 Sign in  

[ CAS No. 39891-09-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 39891-09-3
Chemical Structure| 39891-09-3
Structure of 39891-09-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 39891-09-3 ]

Related Doc. of [ 39891-09-3 ]

Alternatived Products of [ 39891-09-3 ]

Product Details of [ 39891-09-3 ]

CAS No. :39891-09-3 MDL No. :MFCD04112495
Formula : C7H5ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :BLGUCBUETMYJTB-UHFFFAOYSA-N
M.W : 152.58 Pubchem ID :1475128
Synonyms :

Calculated chemistry of [ 39891-09-3 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.77
TPSA : 36.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.4
Log Po/w (XLOGP3) : 1.47
Log Po/w (WLOGP) : 1.8
Log Po/w (MLOGP) : 0.73
Log Po/w (SILICOS-IT) : 2.27
Consensus Log Po/w : 1.53

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.09
Solubility : 1.24 mg/ml ; 0.00813 mol/l
Class : Soluble
Log S (Ali) : -1.85
Solubility : 2.17 mg/ml ; 0.0142 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.12
Solubility : 0.117 mg/ml ; 0.000767 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 39891-09-3 ]

Signal Word:Danger Class:8,6.1
Precautionary Statements:P261-P280-P301+P310-P305+P351+P338 UN#:2923
Hazard Statements:H301-H315-H318-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 39891-09-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 39891-09-3 ]
  • Downstream synthetic route of [ 39891-09-3 ]

[ 39891-09-3 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 39891-09-3 ]
  • [ 6271-78-9 ]
Reference: [1] Catalysis Science and Technology, 2017, vol. 7, # 17, p. 3747 - 3757
  • 2
  • [ 773837-37-9 ]
  • [ 70258-18-3 ]
  • [ 39891-09-3 ]
YieldReaction ConditionsOperation in experiment
85% at 20℃; for 20 h; Reflux Example 46 (1 R)-1-(6-amιno-Pyrιdιn-3-yl-acetyl amιno)-2-(2-hvdroxy-3-carboxyphenyl)ethyl-1- boronic acid formateStep 1. Synthesis of (6-chloropyridin-3-yl) acetonitrite. To a solution of 2-chloro-5-(chloromethyl)pyrιdιne (25 g, 0 154 mol) in ethanol (40 mL) stirring at 0 °C was added a solution of sodium cyanide (8 17 g 0 167 mol) in water (18 mL) The reaction mixture was refluxed for 2 hours then stirred at ambient temperature for a further 18 hours The solvent was evaporated in vacuo and the residue extracted from water into DCM (500 mL), washed with brine dned over sodium sulfate, filtered and evaporated in vacuo The crude material was purified by column chromatography over silica gel eluting with 70/30 DCM/hexanes to afford 20 g (85percent) of product as brown oil which solidified on standing ESI-MS m/z 153 (MH)*
63% at 0 - 100℃; for 3 h; To a stirred solution of 2-chloro-5-(chloromethyl)pyridine (1 g, 6.17 mmol, 1.0 equiv.) in ethanol (10 ml_) was added the solution of NaCN (325 mg, 6.79 mmol, 1.1eq) in H20 (10 mL) dropwise at 0°C and stirred for 3h at 100 °C. The reaction mixture was diluted with water (50ml), extracted with ethyl acetate (70ml_x2) washed with brine (20mL), dried over anhydrous Na2S04 and evaporated under vacuum. The crude was purified by using silica gel chromatography (100-200 mesh) using ethyl acetate /petrol ether (3:7) to get 2-(6- chloropyridin-3-yl)acetonitrile (400 mg, 63 percent) as a yellow solid.
63% at 0 - 100℃; for 3 h; To a stirred solution of 2-chloro-5-(chloromethyl)pyridine (1 g, 6.17 mmol, 1.0 eq) in ethanol (10 mL) was added the solution of NaCN (325 mg, 6.79 mmol, 1.1 eq) in water (10 mL) dropwise at 0 °C and then stirred for 3 h at 100 °C. The reaction mixture was diluted with water (50 mL), extracted with ethyl acetate (2 x 70 mL) washed with brine (20 mL). The organic layer was dried over anhydrous sodium sulphate and evaporated under vacuum. The crude was purified by using silica gel chromatography (100-200 mesh) using ethyl acetate /petrol ether (3:7) to get 2-(6-chloropyridin-3-yl)acetonitrile (400 mg, 63 percent) as a yellow solid.
63% at 0 - 100℃; for 3 h; Step 1:
To a stirred solution of 2-chloro-5-(chloromethyl)pyridine (1 g, 6.17 mmol, 1.0 equiv.) in ethanol (10 mL) was added the solution of NaCN (325 mg, 6.79 mmol, 1.1 eq) in H2O (10 mL) dropwise at 0° C. and stirred for 3 h at 100° C.
The reaction mixture was diluted with water (50 ml), extracted with ethyl acetate (70 mL*2) washed with brine (20 mL), dried over anhydrous Na2SO4 and evaporated under vacuum.
The crude was purified by using silica gel chromatography (100-200 mesh) using ethyl acetate/petrol ether (3:7) to get 2-(6-chloropyridin-3-yl)acetonitrile (400 mg, 63percent) as a yellow solid.
63% at 0 - 100℃; for 3 h; Step 1
To a stirred solution of 2-chloro-5-(chloromethyl)pyridine (1 g, 6.17 mmol, 1.0 eq) in ethanol (10 mL) was added the solution of NaCN (325 mg, 6.79 mmol, 1.1 eq) in water (10 mL) dropwise at 0° C. and then stirred for 3 h at 100° C.
The reaction mixture was diluted with water (50 mL), extracted with ethyl acetate (2*70 mL) washed with brine (20 mL).
The organic layer was dried over anhydrous sodium sulfate and evaporated under vacuum.
The crude was purified by using silica gel chromatography (100-200 mesh) using ethyl acetate/petrol ether (3:7) to get 2-(6-chloropyridin-3-yl)acetonitrile (400 mg, 63percent) as a yellow solid.
21 g With sodium carbonate In ethanol for 4 h; Reflux 16.2 g 2-chloropyridine benzyl chlorine, 5.1 g of sodium cyanide are added to a 250 ml four-mouthed flask. Add 150 ml ethanol, 11 g sodium carbonate. Heat to reflux. Reflux reaction for 4 hours. After the reaction, prolapsed ethanol, add 100 g water and stirred, filtered to obtain 21 g 2-chloropyridine acetonitrile.

Reference: [1] Patent: WO2010/130708, 2010, A1, . Location in patent: Page/Page column 105
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 7, p. 2168 - 2173
[3] Patent: WO2013/13817, 2013, A1, . Location in patent: Page/Page column 111
[4] Patent: WO2013/13815, 2013, A1, . Location in patent: Page/Page column 221
[5] Patent: US2013/29961, 2013, A1, . Location in patent: Paragraph 0705
[6] Patent: US2013/29962, 2013, A1, . Location in patent: Paragraph 1077; 1085
[7] Journal of the American Chemical Society, 2013, vol. 135, # 16, p. 6289 - 6299
[8] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 1079 - 1089
[9] Patent: CN105669584, 2016, A, . Location in patent: Paragraph 0079; 0080; 0081
  • 3
  • [ 70258-18-3 ]
  • [ 143-33-9 ]
  • [ 39891-09-3 ]
YieldReaction ConditionsOperation in experiment
96% at 0 - 100℃; for 20 h; To a solution of 2-chloro-5-(chlofomethyl)pyridine (75g, 0.46mol) in ethanol (120ml) stirring at O0C, was added a solution of sodium cyanide (24.5Og, 0.50mol) in water (40ml). The reaction mixture heated at 10O0C for 2 hours then stirred at room temperature for a further 18 hours. The solvent was evaporated in vacuo and the residue extracted from water into dichloromethane (500ml), washed with brine, dried over sodium sulphate, filtered and evaporated in vacuo. The crude material was purified by column chromatography over silica gel eluting with dichloromethane. The title compound was obtained as a brown oil which solidified on standing (67g, 0.44mol, 96percent). 1H-NMR (CDCl3, 400MHz); δ 3.7 (s, 2H), 7.4 (d, 1H), 7.65 (d, 1H), 8.4 (s, 1H).
45.6% With potassium iodide In ethanol; water at 85℃; for 5 h; 1.17.a
(6-chloro-pyridin-3-yl)-acetonitrile
A solution of 7.5 g (41.66 mmol) of 2-chloro-5-chloromethyl-pyridine, dissolved in 100 ml of ethanol, is added dropwise to a solution of 6.91 g (41.66 mmol) of potassium iodide and 2.24 g (49.01 mmol) of sodium cyanide in 400 ml of an ethanol/water mixture (9:1).
Then the reaction mixture is heated to 85° C. for five hours.
The solvent is substantially distilled off in vacuo and the residue is extracted with water and ethyl acetate.
The organic phase is washed with water three times and dried over sodium sulphate.
The purification is carried out by column chromatography on silica gel (eluant: dichloromethane/ethanol).
Yield: 2.9 g (45.6percent of theory);
C7H5ClN2 (M=152.58);
calc.: molar peak (M+H)+: 151/153 fnd.: molar peak (M+H)+: 151/153.
Reference: [1] Patent: WO2007/45989, 2007, A1, . Location in patent: Page/Page column 9; 24
[2] Patent: US2004/242572, 2004, A1, . Location in patent: Page/Page column 44
[3] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004, vol. 43, # 4, p. 864 - 868
  • 4
  • [ 70258-18-3 ]
  • [ 151-50-8 ]
  • [ 39891-09-3 ]
YieldReaction ConditionsOperation in experiment
89% at 20 - 50℃; To a solution of 2-chloro-5-(chloromethyl)pyridine (5.0 g, 0.031 mol) in ethanol (38 mL) and water (19 mL) was added potassium cyanide (2.41 g, 0.0370 mol) at RT under nitrogen atmosphere.
The reaction mixture was stirred at 50° C. overnight.
The reaction was diluted with water and extracted with DCM.
The organic layer was washed with brine and dried over sodium sulfate.
The solution was filtered and the filtrate was concentrated to afford the desired compound (4.2 g, 89percent).
Analytical LCMS: (M+H)+=153.1.
Reference: [1] Patent: US2008/39457, 2008, A1, . Location in patent: Page/Page column 39
  • 5
  • [ 70258-18-3 ]
  • [ 39891-09-3 ]
YieldReaction ConditionsOperation in experiment
92% at 50℃; for 20 h; A solution of 5.2 g (32 MMOL) of 2-chloro-5-chloromethylpyridine dissolved in 40 mL of ethanol was treated with 20 mL of water and 2.4 g (37 MMOL) of potassium cyanide. The mixture was stirred and heated at 50 °C for 20 hours. The dark mixture was then partitioned between DICHLOROMETHANE and water and the organic layer was washed with brine and dried over sodium sulfate. The solvent was removed under reduced pressure to yield 4.54 g (92percent) of Preparatory Compound E, (6-chloro-3- pyridinyl) acetonitrile, as a dark brown liquid :'H NMR (CDCI3) 8 8.38 (d, J = 3.0 Hz, 1H), 7.71 (dd, J = 3.0 and 7.6 Hz, 1H), 7.42 (d, J = 7.6 Hz, 1H), 3.80 (s, 2H) ppm. GCMS: (EI) m/z 152 (M+).
Reference: [1] Patent: WO2004/57960, 2004, A2, . Location in patent: Page 16
  • 6
  • [ 21543-49-7 ]
  • [ 143-33-9 ]
  • [ 39891-09-3 ]
Reference: [1] Patent: WO2005/56529, 2005, A1, . Location in patent: Page/Page column 44
  • 7
  • [ 70258-18-3 ]
  • [ 39891-09-3 ]
Reference: [1] Patent: US4966902, 1990, A,
  • 8
  • [ 6443-85-2 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
[2] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 9
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 10
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
  • 11
  • [ 6959-48-4 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 12
  • [ 133457-49-5 ]
  • [ 39891-09-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 3, p. 887 - 892
  • 13
  • [ 21543-49-7 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 16, p. 6289 - 6299
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 1079 - 1089
  • 14
  • [ 73781-91-6 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 16, p. 6289 - 6299
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 3, p. 1079 - 1089
  • 15
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
  • [ 142892-30-6 ]
Reference: [1] Synthesis, 1992, # 6, p. 528 - 530
  • 16
  • [ 6635-88-7 ]
  • [ 10025-87-3 ]
  • [ 99310-62-0 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 17
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
  • 18
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
  • [ 142892-30-6 ]
Reference: [1] Synthesis, 1992, # 6, p. 528 - 530
  • 19
  • [ 6635-88-7 ]
  • [ 10025-87-3 ]
  • [ 99310-62-0 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 20
  • [ 39891-09-3 ]
  • [ 54127-64-9 ]
Reference: [1] Patent: US4115575, 1978, A,
[2] Patent: US4410530, 1983, A,
[3] Patent: CN105985288, 2016, A, . Location in patent: Paragraph 0103; 0104; 0105
  • 21
  • [ 39891-09-3 ]
  • [ 39891-13-9 ]
YieldReaction ConditionsOperation in experiment
78% at 80℃; for 24 h; A 4.45 g (29.3 MMOL) portion of Preparatory Compound E was treated with 5 mL of concentrated hydrochloric acid. The mixture was stirred and heated at 80 °C for 24 hours. The solution was poured in to ice and the resulting precipitate filtered. Residual water was removed from the sample by treatment with toluene and removal of the azeotrope under reduced pressure. This procedure yielded 3.93 g (78percent) of Preparatory Compound F, (6-chloro-3-pyridinyl) acetic acid, as a fine yellow powder: mp 170-171 °C ;'H NMR (CDCI3) 8 8.34 (d, J = 3. 0 Hz, 1H), 7.66 (dd, J = 3.0 and 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 3.70 (s, 2H) ppm. MS: (ES+) m/z 172 (M+). Anal. CALCD for C7H6CINO2 : C, 49.0 ; H, 3.52 ; N, 8.16. Found: C, 49.3 ; H, 3.53 ; N, 8.11.
Reference: [1] Patent: WO2004/57960, 2004, A2, . Location in patent: Page 16-17
[2] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004, vol. 43, # 4, p. 864 - 868
  • 22
  • [ 39891-09-3 ]
  • [ 64-17-5 ]
  • [ 197376-47-9 ]
YieldReaction ConditionsOperation in experiment
100% at 100℃; for 3 h; To a solution of EtOH (27 mL), concentrated H2SO4 (10 mL) was added dropwise and 2-chloropyridine-5-acetonitrile (2.00 g, 13.1 mmol) was added portionwise. The solution was stirred at 100° C. for three hours. The mixture was added dropwise to a solution of NaHCO3 (30.00 g) in H2O (100 mL) and it was extracted twice with DCM. The organic layer were collected, dried and evaporated to give the title compound (2.60 g, quant.) (0395) C9H10ClNO2 Mass (calculated) [199]; (found) [M+H]+=200.
75%
Stage #1: for 5 h; Reflux
Stage #2: With sodium hydrogencarbonate In water at 20℃;
Step 2. Synthesis of (6-chloropyridin-3-yl) acetic acid ethyl ester. 10 g (65 5 mmol) (6-chloropyrιdιn-3-yl)acetonιtrιle were added to a mixture of 122 mL ethanol and 46 mL cone sulfuric acid and the mixture stirred under reflux for 5 h After cooling to ambient temperature, the reaction mixture was slowly added dropwise. while stirring, to a mixture of 161 g sodium bicarbonate and 450 mL water The aqueous phase was extracted with DCM (three times with 300 mL each time) The combined organic phases were dried over sodium sulfate, filtered and concentrated on a rotary evaporator The crude oil was purified by silica gei chromatography, eluted using a gradient of 2/98(v/v) EtOAc/hexanes to 9/91 (v/v) EtOAc/hexanes to afford 9 8 g (75percent) of product as clear oil ESI-MS m/z 200 (MH)f
13 g for 4 h; Reflux 15.2 g 2-chloropyridin-5-ylacetonitrile was added to a 250 ml four-mouthed flask. Add 150 ml ethanol. 10ml 98percent concentrated sulfuric acid. Heat to reflux. Reflux reaction for 4 hours, reaction finishes, prolapsed ethanol, add 100 g water to stir, is neutral pH the sodium carbonate is used to regulate, filter, to obtain 2-chloro pyridine ethyl acetate 13 g.
Reference: [1] Patent: US2016/297762, 2016, A1, . Location in patent: Paragraph 0394-0395
[2] Patent: WO2006/114213, 2006, A1, . Location in patent: Page/Page column 32
[3] ChemMedChem, 2018, vol. 13, # 10, p. 988 - 1003
[4] Patent: WO2010/130708, 2010, A1, . Location in patent: Page/Page column 105
[5] Patent: WO2004/57960, 2004, A2, . Location in patent: Page 19-20
[6] Patent: US2012/264704, 2012, A1, . Location in patent: Page/Page column 14
[7] Patent: CN105669584, 2016, A, . Location in patent: Paragraph 0079; 0082; 0083
  • 23
  • [ 39891-09-3 ]
  • [ 197376-47-9 ]
Reference: [1] Patent: EP2878339, 2015, A1, . Location in patent: Page/Page column
  • 24
  • [ 39891-09-3 ]
  • [ 717106-69-9 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2004, vol. 43, # 4, p. 864 - 868
  • 25
  • [ 39891-09-3 ]
  • [ 107-04-0 ]
  • [ 854267-89-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 3, p. 887 - 892
[2] Patent: US4966902, 1990, A,
[3] Patent: WO2005/56529, 2005, A1, . Location in patent: Page/Page column 44
  • 26
  • [ 39891-09-3 ]
  • [ 106-93-4 ]
  • [ 854267-89-3 ]
Reference: [1] Patent: WO2013/92616, 2013, A1, . Location in patent: Page/Page column 91
[2] Patent: US2013/158004, 2013, A1, . Location in patent: Paragraph 0550; 0551; 0552; 0553
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 39891-09-3 ]

Chlorides

Chemical Structure| 90196-32-0

[ 90196-32-0 ]

2-Chloro-5-ethylpyridine

Similarity: 0.89

Chemical Structure| 53344-73-3

[ 53344-73-3 ]

2-Chloro-4,4'-bipyridine

Similarity: 0.85

Chemical Structure| 33252-30-1

[ 33252-30-1 ]

2-Chloroisonicotinonitrile

Similarity: 0.84

Chemical Structure| 42260-39-9

[ 42260-39-9 ]

2-Chloro-4-phenylpyridine

Similarity: 0.84

Chemical Structure| 18368-64-4

[ 18368-64-4 ]

2-Chloro-5-methylpyridine

Similarity: 0.83

Nitriles

Chemical Structure| 33252-30-1

[ 33252-30-1 ]

2-Chloroisonicotinonitrile

Similarity: 0.84

Chemical Structure| 101012-32-2

[ 101012-32-2 ]

(2-Chloropyridin-3-yl)acetonitrile

Similarity: 0.80

Chemical Structure| 66909-33-9

[ 66909-33-9 ]

2-Chloro-5-cyano-3-picoline

Similarity: 0.78

Chemical Structure| 1231761-23-1

[ 1231761-23-1 ]

1-Chloroisoquinoline-5-carbonitrile

Similarity: 0.78

Chemical Structure| 875-35-4

[ 875-35-4 ]

2,6-Dichloro-4-methylnicotinonitrile

Similarity: 0.77

Related Parent Nucleus of
[ 39891-09-3 ]

Pyridines

Chemical Structure| 90196-32-0

[ 90196-32-0 ]

2-Chloro-5-ethylpyridine

Similarity: 0.89

Chemical Structure| 53344-73-3

[ 53344-73-3 ]

2-Chloro-4,4'-bipyridine

Similarity: 0.85

Chemical Structure| 33252-30-1

[ 33252-30-1 ]

2-Chloroisonicotinonitrile

Similarity: 0.84

Chemical Structure| 42260-39-9

[ 42260-39-9 ]

2-Chloro-4-phenylpyridine

Similarity: 0.84

Chemical Structure| 18368-64-4

[ 18368-64-4 ]

2-Chloro-5-methylpyridine

Similarity: 0.83